Carnyx Therapeutics Unveils Oral Sleep Candidate CNYX-005 with Preclinical Data Showing Increased NREM Sleep Preclinical study shows 1.5- to 2-hour increase in total sleep time as… CISION PRNewswireOctober 23, 2026
Ascletis' Strategic Partner Sagimet Announces First Patient Dosed in Phase III U.S. Clinical Trial of Denifanstat (ASC40) for Moderate to Severe Acne – With first patient dosed in Phase III clinical trial, Ascletis’ strategic… CISION PRNewswireOctober 23, 2026
Scage Future Announces Effective Date for ADS Ratio Change NANJING, China, Oct. 23, 2026 /PRNewswire/ — Scage Future ("Scage Future" or… CISION PRNewswireOctober 23, 2026
Harbour BioMed Receives China NMPA Approval of Batoclimab Injection (Subcutaneous Injection) for the Treatment of Generalized Myasthenia Gravis The first NMPA-approved anti-FcRn therapy to complete its full clinical development for… CISION PRNewswireOctober 23, 2026
Seatrium and Karpowership Sign Contract for a Series of Whale Class Powership Conversion and Integration Projects SINGAPORE, Oct. 23, 2026 /PRNewswire/ — Seatrium Limited and its strategic partner, floating… CISION PRNewswireOctober 23, 2026
Seatrium and Karpowership Sign Contract for a Series of Whale Class Powership Conversion and Integration Projects SINGAPORE, Oct. 23, 2026 /PRNewswire/ — Seatrium Limited and its strategic partner, floating… CISION PRNewswireOctober 23, 2026
ImmVira Presents Clinical Data from Three Bladder Cancer Studies at ESMO 2026 SUZHOU, China, Oct. 23, 2026 /PRNewswire/ — ImmVira Group ("ImmVira") today announced… CISION PRNewswireOctober 23, 2026
Press Release Hanwha Power Receives ABS Approval in Principle for 1,700 TEU Battery-Powered Containership Design Fully electric propulsion design featuring approximately 151 MWh of energy storage strengthens… CISION PRNewswireOctober 23, 2026
